Clinical Outcomes of Surgery for Age-related Cataract with Intraocular Lens Implantation in Two Hospitals in North-Central Nigeria

Alfin Ruth Jeneral
{"title":"Clinical Outcomes of Surgery for Age-related Cataract with Intraocular Lens Implantation in Two Hospitals in North-Central Nigeria","authors":"Alfin Ruth Jeneral","doi":"10.9734/or/2023/v18i4390","DOIUrl":null,"url":null,"abstract":"Aims: The study aimed to assess the post-operative presenting visual acuity (PVA) and best-corrected visual acuity (BCVA) from six weeks and above post-surgery, of patients operated for age-related cataract with biometry-calculated IOL power and available IOL power implantation, in two hospitals in Jos, Nigeria. \nStudy Design:  Retrospective cross-sectional survey. \nPlace and Duration of Study: Eye units of two mission Hospitals in Jos namely; Bingham University Teaching Hospital and the Faith Alive foundation Hospital, between June and August 2021. \nMethodology: Patients aged 40 years and above, who had undergone surgery for age-related cataract in the preceding 18 months in two hospitals in Jos and were six weeks or more post-surgery were consecutively enrolled into the study, after obtaining informed consent. Socio-demographic data and surgical history were obtained from patients and their surgical records. The PVA and BCVA were assessed and categorized based on World Health Organization guidelines.  \nResults: A total of 87 patients were examined within the study period. Post-operative PVA was good (≥6/18) in 32 (36.8%), borderline (<6/18-6/60) in 41 (47.1%) and poor (<6/60) in 14 (16.1%) participants. After refraction, the proportion of good outcomes increased to 78.2% with only 8.1% of outcomes remaining poor. Biometry-calculated IOL power and available IOL power use did not significantly influence visual outcome (P=.645 and P=.146 for PVA and BCVA respectively). \nConclusion: Majority of participants had post-operative PVA in the borderline category with residual uncorrected refractive error as the principal cause. Regardless of the IOL power implanted, surgery for age-related cataract enhanced patients’ vision. This study has shown that the presence of biometry is a guarantee of refractive success. Hence, refractive outcome audits are essential.","PeriodicalId":287685,"journal":{"name":"Ophthalmology Research: An International Journal","volume":"54 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology Research: An International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/or/2023/v18i4390","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: The study aimed to assess the post-operative presenting visual acuity (PVA) and best-corrected visual acuity (BCVA) from six weeks and above post-surgery, of patients operated for age-related cataract with biometry-calculated IOL power and available IOL power implantation, in two hospitals in Jos, Nigeria. Study Design:  Retrospective cross-sectional survey. Place and Duration of Study: Eye units of two mission Hospitals in Jos namely; Bingham University Teaching Hospital and the Faith Alive foundation Hospital, between June and August 2021. Methodology: Patients aged 40 years and above, who had undergone surgery for age-related cataract in the preceding 18 months in two hospitals in Jos and were six weeks or more post-surgery were consecutively enrolled into the study, after obtaining informed consent. Socio-demographic data and surgical history were obtained from patients and their surgical records. The PVA and BCVA were assessed and categorized based on World Health Organization guidelines.  Results: A total of 87 patients were examined within the study period. Post-operative PVA was good (≥6/18) in 32 (36.8%), borderline (<6/18-6/60) in 41 (47.1%) and poor (<6/60) in 14 (16.1%) participants. After refraction, the proportion of good outcomes increased to 78.2% with only 8.1% of outcomes remaining poor. Biometry-calculated IOL power and available IOL power use did not significantly influence visual outcome (P=.645 and P=.146 for PVA and BCVA respectively). Conclusion: Majority of participants had post-operative PVA in the borderline category with residual uncorrected refractive error as the principal cause. Regardless of the IOL power implanted, surgery for age-related cataract enhanced patients’ vision. This study has shown that the presence of biometry is a guarantee of refractive success. Hence, refractive outcome audits are essential.
尼日利亚中北部两家医院老年性白内障人工晶状体植入术的临床疗效
目的:本研究旨在评估尼日利亚乔斯两家医院的年龄相关性白内障手术患者术后6周及以上的术后表现视力(PVA)和最佳矫正视力(BCVA),这些患者采用生物统计学计算的人工晶状体植入术和可用的人工晶状体植入术。研究设计:回顾性横断面调查。学习地点和时间:乔斯两家特派团医院的眼科,即;宾汉姆大学教学医院和Faith Alive基金会医院,于2021年6月至8月期间。方法:在获得知情同意后,年龄在40岁及以上、在Jos的两家医院接受过年龄相关性白内障手术且术后6周或更长时间的患者连续入组研究。从患者及其手术记录中获得社会人口学数据和手术史。根据世界卫生组织的指南对PVA和BCVA进行了评估和分类。结果:研究期间共检查了87例患者。术后PVA良好(≥6/18)32例(36.8%),边缘性(<6/18-6/60)41例(47.1%),不良(<6/60)14例(16.1%)。经折射后,良好的比例增加到78.2%,仅8.1%的结果仍然较差。生物计量计算的人工晶状体度数和可用的人工晶状体度数对视力结果没有显著影响(P=。645和P=。PVA和BCVA分别为146)。结论:大多数参与者术后PVA处于边缘类别,残余未矫正屈光不正是主要原因。无论植入的人工晶状体功率如何,与年龄相关的白内障手术都能提高患者的视力。本研究表明,生物测量的存在是屈光成功的保证。因此,屈光结果审计是必不可少的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信